about
The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in miceA pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients with advanced renal cell carcinoma.A standardized and reproducible urine preparation protocol for cancer biomarkers discoveryPrognostic significance of P27 (Kip 1) and MUC1 in papillary transitional cell carcinoma of the urinary bladder.Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccineRecent progress in mouse models for tumor suppressor genes and its implications in human cancer.Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding.Human urine proteomics: building a list of human urine cancer biomarkers.
P2860
Q21562496-8856E963-E9AF-423F-BC0D-A75BDECDBBE2Q34111701-4CB553B5-4102-419B-BB00-7B6290D2DDEEQ34449879-AD8023CA-0ADC-4A60-974F-DFD1065887BDQ34565890-CCD6B6CA-E241-47CB-99C4-378E0B81C433Q34675774-4B55F5B6-8722-403C-9C12-A2B013562D50Q36929407-12C085FD-737A-4395-B59E-78D96D937027Q37108161-69CE6B93-3201-4296-BAB7-B2F83FA371E3Q37890422-8E41A8FB-5663-4E9F-A6B7-B574F67F53E9
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Biomarker discovery in urogenital cancer.
@ast
Biomarker discovery in urogenital cancer.
@en
type
label
Biomarker discovery in urogenital cancer.
@ast
Biomarker discovery in urogenital cancer.
@en
prefLabel
Biomarker discovery in urogenital cancer.
@ast
Biomarker discovery in urogenital cancer.
@en
P2860
P1433
P1476
Biomarker discovery in urogenital cancer.
@en
P2093
Jonathan Said
P2860
P356
10.1080/13547500500215050
P478
10 Suppl 1
P577
2005-11-01T00:00:00Z